Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by ontheDLon Jul 08, 2011 3:13pm
354 Views
Post# 18812117

RE: NR - Golden Predator drills 92.0 m of 2.02 g/t

RE: NR - Golden Predator drills 92.0 m of 2.02 g/tNorthern Securities responds to GPD initiating resource calculation at Grew Creek:
Kwong-Mun Achong Low, Northern Securities(7/6/11)"Golden Predator has completed its 20-hole exploration program (25mspacing) at the Carlos Zone, Grew Creek property and intends to completea resource estimate by year-end. Hole GC11-281 with 92m of 2.0 g/t goldis the best hole drilled this year on a gram-meter basis and edges outhole GC11-276 with 47m of 3.8 g/t gold (released June 21, 2011). . . Theexploration potential has just started to unfold, in our opinion,considering the interpretation of the structure based on existinggeophysical and geochemical data which supports the possibility ofmultiple mineralized zones on the property."
Bullboard Posts